Suministro del medicamento cuyo Principio Activo es DARATUMUMAB para el Complejo Asistencial Universitario de Salamanca.
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- Jun 23, 2025Expired
- Award
- Price only
Brief
Suministro del medicamento cuyo Principio Activo es DARATUMUMAB.
Farmasøytisk engroshandel
Result
- JANSSEN-CILAG, S.A.Winner
- 1Number of tenders received
- €1,636,131Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Precio.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Gerencia de Atención Especializada de Salamanca
From the notice
Suministro del medicamento cuyo Principio Activo es DARATUMUMAB.
Contact
Gerencia de Atención Especializada de Salamancauca.husa@saludcastillayleon.es- Result · PrequalificationType
- SalamancaLocation
- 33690000Main codeVarious medicinal products